Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Proteologics Inc.

www.proteologics.com

Latest From Krauth Medical KG

In Medical Devices, Is "Good Enough" Good Enough?

Device companies have historically been rewarded for even incremental technology enhancements with premium pricing by a price-insensitive customer, all in the spirit that no improvement to the clinical episode would go unrewarded. But in a health care system that is trying to balance exploding costs and greater access, such a goal becomes simply unaffordable. Instead, payors, hospitals and even physicians, encouraged by government policy makers, will increasingly look for technology that delivers an acceptable clinical outcome at a better price.
Medical Device Europe

Invatec: Translating Global Success in Vascular Devices to the US Market

Invatec has grown to be the leading native European interventional vascular device company and has now set its sights on the US market. By focusing first on peripherals and following with drug-eluting balloons, not stents, Invatec is looking to compete against the major device companies on their home turf.
Medical Device Middle East and Africa

Invatec: From Garage to Global Cardiology Brand

Staying close to the customer has become a cliche--one that most companies begin by adhering to, but which becomes more difficult to maintain as a company grows. Invatec started as a family-run business centered around turning physicians' ideas into new products. The success of Invatec's initial products led to the company's transformation into one selling both cardiology devices and innovative products in the carotid and peripheral markets. Invatec started by building a growing global business outside of the US, and it is seeing early success from its initial US product introductions, where it is challenging the major cardiology companies on their home turf.
Medical Device Strategy

LDR: Betting on Cervical

Though the company's founders played a crucial role in the development of the first artificial lumbar disc replacements, LDR has itself always taken a somewhat conrtrarian view toward the promise of lumbar disc replacement. Rather the company is betting on the promise of cervical discs, while rounding out its lumbar line with more traditional fusion approaches.
Medical Device Innovation
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Proteologics Inc.
  • Senior Management
  • Joshua Levine, CEO
    Esti Hayun, CFO
    Ety Klinger, PhD, VP, R&D
  • Contact Info
  • Proteologics Inc.
    Phone: (972) 894-75666
    40 Ramland Rd. S.
    Ste. 10
    Orangeburg, NY 10962
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register